Biotech and Pharmaceutical
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  US Device


Market Summary

Company Profiles


Research Store

Biotech Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

Deutsche Bank 

60 Wall Street

New York  New York  10005-2858  U.S.A.
Phone: 212-250-2500 Fax: 212-797-4664


Deutsche Bank ranks among the global leaders in corporate banking and securities, transaction banking, asset management, and private wealth management, and has a significant private and business banking franchise in Europe. Deutsche Bank competes to be the leading global provider of financial solutions for demanding clients creating exceptional value for its shareholders and people. With Euro 1,097 billion in assets and 67,474 employees, Deutsche Bank offers unparalleled financial services in 73 countries throughout the world.

Deutsche Bank’s Health Care Investment Banking team is one of the largest and most experienced health care specialist banking groups with approximately 70 professionals worldwide. The group has demonstrated cross-border expertise with unique insights into the global market. They provide for unmatched capital strength along with the ability to rapidly commit significant capital.

The group taps resources across the bank’s integrated platform, including the market’s savviest financing and industry pros. The senior bankers average 16 years of health care investment banking experience and have deep domain expertise in all industry segments and sub-sectors.

Voted the World’s Best Health Care Investment Bank in 2006 by Global Finance, Deutsche Bank is committed to building long-term relationships and providing world-class advisory services for all industry sub-sectors.

Recent landmark life sciences transactions include:

  • Sole financial advisor to Stiefel Laboratories in its $640 million acquisition of Connectics Corporation and sole lead arranger in its $848 million senior secured credit facilities (Pending)
  • Sole book-running manager to United Therapeutics in its $250 million convertible notes offering with call spread (October 2006)
  • Sole financial advisor to Pliva in its $2.5 billion sale to Barr Pharmaceuticals (October 2006)
  • Sole book-running manager to BioMimetic Therapeutics in its $37 million initial public offering (May 2006)
  • Sole book-running manager to Targacept in its $45 million initial public offering (April 2006)
  • Sole book-running manager to Cephalon in its $920 million convertible notes offering with call spread (June 2005)
  • Joint lead-arranger and joint book-running manager in the $3.3 billion debt financing for the LBO of Warner Chilcott by DLJ Merchant Banking Partners, Bain Capital, JPMorgan Partners and Thomas H. Lee Co. (January 2005)

    Contact Information:

    Lee Stettner
    New York

    John Fowler

    Transaction information appears as a matter of record only. Deutsche Bank Securities Inc., a subsidiary of Deutsche Bank AG, conducts investment banking and securities activities in the United States. Deutsche Bank Securities Inc., is a member of NYSE, NASD and SIPC. © 2007 Deutsche Bank AG.

    Last Updated: 01-05-2007

     Key Statistics

    Ownership: Public

    Web Site: Deutsche Bank
    Symbol: DB

  • Industry

     Company News
    Antares Pharma, Inc. (ATRS) To Present At The Deutsche Bank (DB) 39th Annual Health Care Conference 4/24/2014 7:19:30 AM    More...
    INSYS Therapeutics To Present At 39th Annual Deutsche Bank (DB) Health Care Conference 4/23/2014 9:00:38 AM    More...
    Integra LifeSciences Holdings Corporation (IART) To Participate In The 2014 Deutsche Bank (DB) And Bank of America (BAC) Merrill Lynch 2014 Healthcare Conferences In May 4/22/2014 8:56:25 AM    More...
    Gregg Gilbert To Join Deutsche Bank (DB) As Pharmaceutical Sector Analyst 4/11/2014 6:48:17 AM    More...
    bluebird bio To Present At Deutsche Bank (DB) BioFEST Conference 11/27/2013 7:07:17 AM    More...
    Dendreon Corporation (DNDN) Announces Webcast Presentation at Deutsche Bank (DB) BioFEST Conference 11/27/2013 7:03:29 AM    More...
    Neurocrine Biosciences, Inc. (NBIX) To Present At Deutsche Bank (DB) 2013 Biofest And The 25th Annual Piper Jaffray Healthcare Conference 11/27/2013 6:41:06 AM    More...
    Dan Spiegelman, CFO Of BioMarin Pharmaceutical Inc. (BMRN), To Present At The Deutsche Bank 2013 Biofest Conference In Boston 11/26/2013 10:00:50 AM    More...
    Dyax Corp. (DYAX) To Participate In The 2013 Deutsche Bank (DB) BioFEST Conference 11/26/2013 6:54:49 AM    More...
    Biogen Idec, Inc. (Massachusetts) (BIIB) To Present At The 2013 Deutsche Bank (DB) BioFEST 11/26/2013 6:45:46 AM    More...